Clinical Trial (CLIN2) Awards
Advancing Stem Cell and Gene Therapies
CLIN2 applications will open on May 22, 2025
Applications are due by June 30, 2025
Photo Credit: Barbara Ries of UCSF
Clinical Programs at CIRM
The mission of the California Institute for Regenerative Medicine (CIRM) is to accelerate world class science to deliver transformative regenerative medicine treatments in an equitable manner to a diverse California and world.
CIRM’s CLIN2 funding program will support the completion of Phase 1, 2, or 3 clinical trials— including pivotal trials— for regenerative medicine therapies that address significant unmet medical needs and have the potential to provide transformative benefits to patients, their families, and the healthcare system. Through this program, CIRM creates funding opportunities for regenerative medicine clinical research that otherwise do not exist or are of limited scope. CIRM will devote internal resources and leverage a network of world-class subject matter experts to help ensure that funded projects have a comprehensive clinical development strategy aimed at obtaining marketing approval with a well-developed plan for ensuring access and affordability.
CLIN2 Awards: Key Information
Expected Outcomes
The expected outcome of a CLIN2 award is completion of a single interventional clinical trial.
Award Amount & Duration
The award amount ranges from $8 million to $15 million and is dependent on the stage of the clinical trial and the for-profit versus non-profit status of the applicant organization. Projects may have a maximum planned duration of four years.
See the Program Announcement for more details.
Project Eligibility
California or non-California-based for-profit or non-profit organizations may apply.
Funding Allocation
CIRM anticipates funding between 9-16 CLIN2 awards in fiscal year 2025-2026, contingent on the number of applications at each funding level that are recommended.
Download the CLIN2 Program Announcement (PA) for more information on award eligibility, review criteria, and the application process.

How to Submit an Application:
Log in with your existing CIRM username and password. If you do not have a username, click the “New User” link and follow the instructions to create a CIRM username and password.
Select the tab labeled “Open Programs” under the section labeled “RFAs and Programs Open for Applications,” and click on the “Start a Grant Application” link for the selected program.
Click on the appropriate link and follow the instructions. Proposal templates can be located and submitted under the “Uploads” section.
Click on the “Done with Application” button. After completing all the mandatory sections, the “Done with Application” button will be enabled.
Note: Once submitted, you can no longer make changes to your application.
Select the tab labeled “Your Applications” and check the table under the section labeled “Your Submitted Applications.” Once the submission process has been completed, you will see your application number and project title listed.
Applications for the CLIN2 Awards will open on May 22, 2025. Application deadline is June 30, 2025.
CIRM Grants Policies, FAQs, and Primers
- Data Sharing and Management Requirements
- Access and Affordability Planning Requirements [link to document]
- Allowable Costs and co-funding FAQ
- Commercialization Rights Primer (IP, Revenue Sharing, Pricing, Access, March-in Rights) [link to document]
- Grants Administration Policy for Clinical Stage Projects
Clinical Development Resources
CLIN2 Application Resources
CIRM will host a live informational webinar and Q&A session on May 28, 2025 at 11:00 AM.
CIRM Clinical Program Funding Opportunity: CLIN2 Award. This webinar provides an opportunity for prospective applicants to learn about CIRM’s updated CLIN2 Funding Opportunity and how to assemble a competitive application. CIRM team members will share information on award scope and structure, preference topics, and the submission process.
CLIN2 FAQ [TBD]
[Placeholder text from DISC4]
The applicant organization must be a California organization per CIRM’s definition. A “California Organization” is a for-profit or non-profit organization or is a California-domiciled wholly owned subsidiary of a non-California organization (any entity that does not qualify as a California Organization) that meets all of the following criteria:
- Employment and Payroll: Employs at least one W-2 employee; and more than 50% of its W-2 employees, whether part-time or full-time, who are paid in any manner (e.g., wage, salary, commission, equity), must be domiciled full-time in California and be required to file California state income taxes due to their employment with the organization.
- Management of Award Activities: The Principal Investigator (PI) must be physically located in California while overseeing all project activities.
- Intellectual Property Rights: In the case of a California-domiciled wholly owned subsidiary of a non-California organization, the subsidiary must retain exclusive rights to any intellectual property arising out of the CIRM-funded project as well as any pre-existing IP rights held by the parent organization.
The maximum duration of a DISC4 Award is four years, and the award will be capped at $13 million total costs inclusive of direct facilities and indirect costs. Additional funding of up to $1 million ($14 million total) may be requested IF matching funds of equivalent or greater value are provided, please refer to the PA for eligible matching fund contributions.
To be eligible, the proposed project must satisfy the following requirements:
- The proposed project must address knowledge gap(s) or research bottleneck(s) in the study of human diseases
- The proposal must include studies that employ human stem cells or genetic research as part of the central approach or hypothesis
- Strong justification must be provided for any proposed use of non-human models
The Core applicant team must be multi-institutional and include at least five CA-based investigators – one Principal Investigator and at least four Co-investigators. The broader team may include any number of additional Key Personnel – including collaborators, consultants, subcontractors, etc.
All Core Team members (Principal Investigators and designated Co-investigators) must be employed by California-based organizations. In addition, Principal Investigators and Co-Investigators must commit at least 15% (PI) or 10% (co-I) effort respectively to working on this project and all effort must be expended in California.
The broader team (which includes key personnel) must include at least one data project manager, at least one member with relevant clinical expertise, at least one member with industry/translational experience, and at least one member with relevant computational biology or bioinformatic expertise.
Non-CA-based investigators are not eligible to serve as PI or Co-I on DISC4 awards. However, DISC4 applicants are allowed to budget grant funds to support a non CA-based collaborator through a grant subcontract, provided the out-of-state organization does NOT retain the intellectual property or independent publication rights of any intellectual property (e.g., invention, technology, data) arising out of the CIRM-funded project.
In addition, collaborating non-CA investigators and organizations may contribute research activities to the overall project at no cost to the team (in-kind contribution). While non-CA investigators and organizations will not receive CIRM funds in this arrangement, the contributed research may qualify as matching funds, which would allow the applicant team to request additional CIRM funding. Applicants should refer to the section on “Matching funds” in the RFA or contact CIRM staff to learn more.
An investigator cannot be listed as a Principal Investigator on more than one application. An investigator may be included in the core team of up to two applications. For instance, a researcher may be listed as a co-investigator on two applications OR a Principal Investigator on one application and a co-investigator on a second application.
Programmatic questions regarding this award should be emailed to discovery@cirm.ca.gov with the subject line “CLIN2”. Specific questions related to budget and Grants Administration policies should be emailed to grantsmanagement@cirm.ca.gov with the subject line “CLIN2”.
Keep Up-To-Date
Subscribe for email updates on CLIN2 and other CIRM funding opportunities.